WR6-25146-37385
2 vaccinations
1 coded response
9 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 770 / TX
- Registered
- 2021-07-14
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-06-03
Dose 1 — Pfizer-BioNTech
-
2021-07-01
Dose 2 — Pfizer-BioNTech
-
2021-07-14
Registered in v-safe
- 2021-07-14
- 2021-07-17
- 2021-07-22
- 2021-07-29
- 2021-08-05
- 2021-08-12
- 2021-09-30
-
2021-12-30
Survey response — 6 months, dose 2MedDRA: Cough, Oropharyngeal pain, Rhinorrhoea — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Sore throat, dry cough, runny noseMedDRA releases: 2024-11 · check-in free text available
- 2022-07-03
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-06-03 | Pfizer-BioNTech | No |
| 2 | 2021-07-01 | Pfizer-BioNTech | No |
Free text
Release 10 — 6 months, dose 2
Symptoms: Sore throat, dry cough, runny nose
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release